Legal

Terms of Service

Last updated: January 2025

Please read these Terms of Service carefully before using the RSD-RS platform. By registering for and using our services, you agree to be bound by these terms.

1. Definitions

  • "Platform" refers to the RSD-RS web application, API, and related services.
  • "User" or "You" refers to the healthcare professional or organisation registered to use the Platform.
  • "Patient Data" refers to the anonymised clinical assessment data entered into the Platform.
  • "Research Data" refers to aggregated, anonymised data used for scientific research purposes.
  • "Instruments" refers to the RSD-RS assessment questionnaires and scoring systems.

2. Acceptance of Terms

By creating an account and using the RSD-RS Platform, you confirm that:

  • You are a qualified healthcare professional or work within a clinical/research organisation
  • You have the authority to enter into this agreement on behalf of your organisation
  • You will use the Platform in accordance with applicable laws and professional standards
  • You have read and understood our Privacy Policy and Data Protection Policy

3. Description of Service

RSD-RS provides a clinical assessment platform for measuring rejection sensitivity dysphoria in individuals with ADHD. The Platform includes:

  • Access to validated assessment instruments (RSD-RS-30, RSD-RS-10, and variants)
  • Patient record management with anonymous identifiers
  • Automated scoring and clinical report generation
  • Longitudinal tracking and change measurement
  • Optional contribution to the global research initiative

4. User Responsibilities

4.1 Clinical Use

You acknowledge and agree that:

  • The RSD-RS instruments are clinical tools to be used as part of a comprehensive assessment
  • Results should be interpreted by qualified professionals in context of the full clinical picture
  • The Platform does not provide diagnoses; it measures dimensional constructs
  • You are responsible for appropriate clinical decision-making based on results
  • The instruments are currently in validation phase; severity bands are provisional

4.2 Data Entry

You agree to:

  • Enter only anonymised patient data - no names, dates of birth, or identifiable information
  • Use only the system-generated patient identifiers
  • Maintain your own secure records linking patient identifiers to actual patients
  • Not attempt to re-identify patients from Research Data
  • Ensure accuracy of demographic and clinical information entered

4.3 Account Security

You are responsible for:

  • Maintaining the confidentiality of your account credentials
  • All activities that occur under your account
  • Notifying us immediately of any unauthorised access
  • Ensuring appropriate access controls within your organisation

5. Research Contribution

If you opt in to research contribution (enabled by default), you agree that:

  • Anonymised assessment data will be included in the global research dataset
  • This data will be used to validate the RSD-RS instruments and develop normative data
  • Aggregated findings may be published in scientific journals
  • No individual patients or clinics will be identifiable in publications
  • You may opt out at any time via Settings; existing contributed data remains in aggregate datasets
  • Research use is governed by ethical principles and relevant regulations

6. Intellectual Property

The RSD-RS instruments, Platform, and associated materials are protected by intellectual property rights:

  • The instruments are provided for clinical and research use under licence
  • You may not modify, reproduce, or redistribute the instruments without permission
  • Generated reports may be shared with patients and other healthcare providers as appropriate
  • You retain rights to your clinical notes and interpretations

7. Subscription and Fees

7.1 Early Adopter Programme

Users who register during the validation phase and complete 100 or more assessments receive 12 months of free access to all platform features.

7.2 Paid Subscriptions

After the 12-month early adopter period, users may continue on a paid subscription or export their data. We will notify users before their free period ends.

8. Disclaimers and Limitations

8.1 Clinical Disclaimer

THE RSD-RS INSTRUMENTS ARE PROVIDED AS CLINICAL TOOLS AND DO NOT CONSTITUTE MEDICAL ADVICE. THE PLATFORM DOES NOT DIAGNOSE CONDITIONS OR RECOMMEND TREATMENTS. ALL CLINICAL DECISIONS REMAIN THE RESPONSIBILITY OF THE QUALIFIED HEALTHCARE PROFESSIONAL.

8.2 Validation Status

The instruments are currently undergoing international validation. Severity bands and clinical cut-offs are provisional and based on item anchor severity rather than population norms. Results should be interpreted with appropriate clinical judgement.

8.3 Service Availability

While we strive for continuous availability, we do not guarantee uninterrupted access. We are not liable for any losses arising from service interruptions.

9. Termination

We may terminate or suspend your account if you:

  • Violate these Terms of Service
  • Enter identifiable patient information
  • Misuse the Platform or Research Data
  • Engage in fraudulent activity

Upon termination, you may export your data. Contributed Research Data remains in aggregate datasets.

10. Changes to Terms

We may update these terms from time to time. Material changes will be notified via email and/or Platform notification. Continued use after changes constitutes acceptance of the revised terms.

11. Governing Law

These terms are governed by the laws of England and Wales. Any disputes shall be subject to the exclusive jurisdiction of the courts of England and Wales.

12. Contact

For questions about these terms, please contact us at: legal@rsdrs.com